Condensed Consolidated Statements of Shareholders' Equity - USD ($) $ in Thousands	Total	Common Stock	Additional Paid- In Capital	Accumulated Other Comprehensive (Loss) Income	Retained Deficit
Beginning balance at Sep. 30, 2023	$ 88,365	$ 142	$ 126,963	$ (1,695)	$ (37,045)
Beginning balance (in shares) at Sep. 30, 2023		14,186,000
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income (loss)	(9,358)				(9,358)
Translation adjustment	269			269
Stock compensation expense	317		317
Stock options exercised	28		28
Stock options exercised (in shares)		5,000
Ending balance at Dec. 31, 2023	79,621	$ 142	127,308	(1,426)	(46,403)
Ending balance (in shares) at Dec. 31, 2023		14,191,000
Beginning balance at Sep. 30, 2023	88,365	$ 142	126,963	(1,695)	(37,045)
Beginning balance (in shares) at Sep. 30, 2023		14,186,000
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income (loss)	(7,950)
Ending balance at Jun. 30, 2024	81,718	$ 142	128,146	(1,575)	(44,995)
Ending balance (in shares) at Jun. 30, 2024		14,209,000
Beginning balance at Dec. 31, 2023	79,621	$ 142	127,308	(1,426)	(46,403)
Beginning balance (in shares) at Dec. 31, 2023		14,191,000
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income (loss)	970				970
Translation adjustment	(50)			(50)
Stock compensation expense	350		350
Stock options exercised (in shares)		18,000
Ending balance at Mar. 31, 2024	80,891	$ 142	127,658	(1,476)	(45,433)
Ending balance (in shares) at Mar. 31, 2024		14,209,000
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income (loss)	438				438
Translation adjustment	(99)			(99)
Stock compensation expense	488		488
Ending balance at Jun. 30, 2024	81,718	$ 142	128,146	(1,575)	(44,995)
Ending balance (in shares) at Jun. 30, 2024		14,209,000
Beginning balance at Sep. 30, 2024	$ 82,358	$ 143	128,466	(720)	(45,531)
Beginning balance (in shares) at Sep. 30, 2024	14,258,879	14,259,000
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income (loss)	$ 312				312
Translation adjustment	(711)			(711)
Stock compensation expense	333		333
Stock options exercised	150		150
Stock options exercised (in shares)		30,000
Ending balance at Dec. 31, 2024	82,442	$ 143	128,949	(1,431)	(45,219)
Ending balance (in shares) at Dec. 31, 2024		14,289,000
Beginning balance at Sep. 30, 2024	$ 82,358	$ 143	128,466	(720)	(45,531)
Beginning balance (in shares) at Sep. 30, 2024	14,258,879	14,259,000
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income (loss)	$ (31,394)
Ending balance at Jun. 30, 2025	$ 51,718	$ 143	129,577	(1,077)	(76,925)
Ending balance (in shares) at Jun. 30, 2025	14,313,963	14,314,000
Beginning balance at Dec. 31, 2024	$ 82,442	$ 143	128,949	(1,431)	(45,219)
Beginning balance (in shares) at Dec. 31, 2024		14,289,000
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income (loss)	(31,812)				(31,812)
Translation adjustment	115			115
Stock compensation expense	290		290
RSU vested		25,000
Ending balance at Mar. 31, 2025	51,035	$ 143	129,239	(1,316)	(77,031)
Ending balance (in shares) at Mar. 31, 2025		14,314,000
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income (loss)	106				106
Translation adjustment	239			239
Stock compensation expense	338		338
Ending balance at Jun. 30, 2025	$ 51,718	$ 143	$ 129,577	$ (1,077)	$ (76,925)
Ending balance (in shares) at Jun. 30, 2025	14,313,963	14,314,000